These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11596440)

  • 21. [Carnitine deficiency].
    Przyrembel H
    Ned Tijdschr Geneeskd; 1988 Jun; 132(23):1047-51. PubMed ID: 3386765
    [No Abstract]   [Full Text] [Related]  

  • 22. [Carnitine transporter defect].
    Yorifuji S
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):398-400. PubMed ID: 9590081
    [No Abstract]   [Full Text] [Related]  

  • 23. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
    Kato Y; Sugiura M; Sugiura T; Wakayama T; Kubo Y; Kobayashi D; Sai Y; Tamai I; Iseki S; Tsuji A
    Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of dye-binding/high-resolution thermal denaturation for the identification of mutations in the SLC22A5 gene.
    Dobrowolski SF; McKinney JT; Amat di San Filippo C; Giak Sim K; Wilcken B; Longo N
    Hum Mutat; 2005 Mar; 25(3):306-13. PubMed ID: 15714519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency.
    Cederbaum SD; Koo-McCoy S; Tein I; Hsu BY; Ganguly A; Vilain E; Dipple K; Cvitanovic-Sojat L; Stanley C
    Mol Genet Metab; 2002 Nov; 77(3):195-201. PubMed ID: 12409266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional variants of OCTN cation transporter genes are associated with Crohn disease.
    Peltekova VD; Wintle RF; Rubin LA; Amos CI; Huang Q; Gu X; Newman B; Van Oene M; Cescon D; Greenberg G; Griffiths AM; St George-Hyslop PH; Siminovitch KA
    Nat Genet; 2004 May; 36(5):471-5. PubMed ID: 15107849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDZ adaptor protein PDZK2 stimulates transport activity of organic cation/carnitine transporter OCTN2 by modulating cell surface expression.
    Watanabe C; Kato Y; Sugiura T; Kubo Y; Wakayama T; Iseki S; Tsuji A
    Drug Metab Dispos; 2006 Nov; 34(11):1927-34. PubMed ID: 16896066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of molecular diagnosis in the accurate diagnosis of systemic carnitine deficiency.
    Hitomi T; Matsuura N; Shigematsu Y; Okano Y; Shinozaki E; Kawai M; Kobayashi H; Harada KH; Koizumi A
    J Genet; 2015 Mar; 94(1):147-50. PubMed ID: 25846890
    [No Abstract]   [Full Text] [Related]  

  • 30. OCTN3: A Na+-independent L-carnitine transporter in enterocytes basolateral membrane.
    Durán JM; Peral MJ; Calonge ML; Ilundáin AA
    J Cell Physiol; 2005 Mar; 202(3):929-35. PubMed ID: 15389639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Carnitine deficiency myopathy (author's transl)].
    Jerusalem F
    Nervenarzt; 1980 May; 51(5):266-71. PubMed ID: 7007897
    [No Abstract]   [Full Text] [Related]  

  • 32. Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2.
    Inano A; Sai Y; Nikaido H; Hasimoto N; Asano M; Tsuji A; Tamai I
    Biopharm Drug Dispos; 2003 Nov; 24(8):357-65. PubMed ID: 14595704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells.
    Kobayashi D; Irokawa M; Maeda T; Tsuji A; Tamai I
    Reproduction; 2005 Dec; 130(6):931-7. PubMed ID: 16322553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cationic polyrotaxanes effectively inhibit uptake via carnitine/organic cationic transporters without cytotoxicity.
    Utsunomiya H; Katoono R; Yui N; Sugiura T; Kubo Y; Kato Y; Tsuji A
    Macromol Biosci; 2008 Jul; 8(7):665-9. PubMed ID: 18366149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exclusive cardiac dysfunction in familial primary carnitine deficiency cases: a genotype-phenotype correlation.
    Yamak A; Bitar F; Karam P; Nemer G
    Clin Genet; 2007 Jul; 72(1):59-62. PubMed ID: 17594400
    [No Abstract]   [Full Text] [Related]  

  • 36. Carnitine.
    Borum PR
    Annu Rev Nutr; 1983; 3():233-59. PubMed ID: 6357236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa.
    Kobayashi D; Tamai I; Sai Y; Yoshida K; Wakayama T; Kido Y; Nezu J; Iseki S; Tsuji A
    Reproduction; 2007 Nov; 134(5):651-8. PubMed ID: 17965255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of intestinal L-carnitine transport.
    Durán JM; Peral MJ; Calonge ML; Ilundáin AA
    J Membr Biol; 2002 Jan; 185(1):65-74. PubMed ID: 11891565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPAR alpha mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis.
    Koch A; König B; Stangl GI; Eder K
    Exp Biol Med (Maywood); 2008 Mar; 233(3):356-65. PubMed ID: 18296741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of OCTN2 and B0,+ in the transport of carnitine through an in vitro model of the blood-brain barrier.
    Berezowski V; Miecz D; Marszałek M; Bröer A; Bröer S; Cecchelli R; Nałecz KA
    J Neurochem; 2004 Nov; 91(4):860-72. PubMed ID: 15525340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.